top of page
Mati Gill
CEO of Aion Labs
Mati Gill is CEO of AION Labs, a venture studio with a first-of-its-kind company
creation model for new start-ups utilizing AI for drug discovery and development.
Supported by the Israeli Government, AION Labs was formed from the unique
alliance of Pfizer, Amazon Web Services, AstraZeneca, Teva Pharmaceuticals, Merck,
the Israel Biotech Fund, Amiti Ventures and BioMed X. Prior to founding AION Labs,
Mati was a senior executive at Teva Pharmaceuticals and served as Chief of Staff



Speakers

















































bottom of page